Aspen Pharmacare Holdings Limited (APNHY) Discusses Proposed Divestment of APAC Operations Excluding China Transcript

Roy Campbell

Good afternoon and welcome. I am Roy Campbell, and I am pleased to announce that I’ve recently joined Aspen in the capacity of Investor Relations, working closely with Stephen, Sean and Sanelisiwe. It is good to be on board, and we look forward to interacting with many of you going forward.

This afternoon is an opportunity to engage with the market and to walk you through a transaction that was announced on the 29th of December, being the divestment of Aspen APAC. Stephen and Sean will take you through a transaction overview, the rationale and some key focus areas.

There is an opportunity to ask questions you can submit via the webcast. Please include your name when you do that so we know where it comes from, and we can follow up on that. And yes, we look forward to interacting. We’ll deal with that after the presentation or later on in the presentation. Thank you again for joining us this afternoon.

I’m going to hand it over to Stephen to open up the discussion. Good afternoon, Stephen.

Stephen Saad
Group CEO & Executive Director

Good afternoon. Good afternoon, everyone. It’s coming a bit like those family meetings with Aspen. We take curveballs, we give curveballs, but it’s all happening. It’s certainly no lack of excitement. But if I think about this APAC divestment, I’ve almost got to go back 25 years in 2001, Gus and I arrived in Australia. We were in our and we had a check of ZAR 10 million, and we bought some products, and we thought we found 2 people, Trevor and Greg, Trevor is still with us, and we